A phase 3b, long-term, observational study of the durability of seroconversion in patients with chronic hepatitis B virus infection who have seroconverted while participating in a previous Gilead-sponsored study of adefovir dipivoxil
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 10 Jan 2014 Status changed from active, no longer recruiting to completed as reported in ClinicalTrials.gov record.
- 26 Feb 2006 New trial record.